[article]
| Titre : |
Hospitalization and Mortality for Insured Patients in the United States with COVID-19 with and without Autism Spectrum Disorder |
| Type de document : |
texte imprimé |
| Auteurs : |
Amber M. DAVIS, Auteur ; Kathryn VAN ECK, Auteur ; Nikeea COPELAND-LINDER, Auteur ; Karen PHUONG, Auteur ; Harolyn M. E. BELCHER, Auteur |
| Article en page(s) : |
p.2347-2354 |
| Langues : |
Anglais (eng) |
| Index. décimale : |
PER Périodiques |
| Résumé : |
Autism spectrum disorder (ASD) is a neuropsychiatric condition that may be associated with negative health outcomes. This retrospective cohort study reveals the odds of hospitalization and mortality based on ASD for a population of insured patients with COVID-19. The odds of hospitalization and mortality for people with ASD were found to be greater than individuals without ASD when adjusted for sociodemographic characteristics. Hospitalization and mortality was associated with a dose-response increase to comorbidity counts (1 to 5+). Odds of mortality remained greater for those with ASD when adjusting for comorbid health conditions. ASD is a risk factor for COVID-19 mortality. Comorbid health conditions play a particular role in increasing the odds of COVID-19 related hospitalization and death for ASD patients. |
| En ligne : |
https://doi.org/10.1007/s10803-023-05971-2 |
| Permalink : |
https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=530 |
in Journal of Autism and Developmental Disorders > 54-6 (June 2024) . - p.2347-2354
[article] Hospitalization and Mortality for Insured Patients in the United States with COVID-19 with and without Autism Spectrum Disorder [texte imprimé] / Amber M. DAVIS, Auteur ; Kathryn VAN ECK, Auteur ; Nikeea COPELAND-LINDER, Auteur ; Karen PHUONG, Auteur ; Harolyn M. E. BELCHER, Auteur . - p.2347-2354. Langues : Anglais ( eng) in Journal of Autism and Developmental Disorders > 54-6 (June 2024) . - p.2347-2354
| Index. décimale : |
PER Périodiques |
| Résumé : |
Autism spectrum disorder (ASD) is a neuropsychiatric condition that may be associated with negative health outcomes. This retrospective cohort study reveals the odds of hospitalization and mortality based on ASD for a population of insured patients with COVID-19. The odds of hospitalization and mortality for people with ASD were found to be greater than individuals without ASD when adjusted for sociodemographic characteristics. Hospitalization and mortality was associated with a dose-response increase to comorbidity counts (1 to 5+). Odds of mortality remained greater for those with ASD when adjusting for comorbid health conditions. ASD is a risk factor for COVID-19 mortality. Comorbid health conditions play a particular role in increasing the odds of COVID-19 related hospitalization and death for ASD patients. |
| En ligne : |
https://doi.org/10.1007/s10803-023-05971-2 |
| Permalink : |
https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=530 |
|  |